Enlivex Therapeutics Ltd. SEC filings and other documents

Explore the latest company documents and SEC filings from Enlivex Therapeutics Ltd., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Description

Event date

Documents and forms

2025

Q2 2025

Aug 29, 2025

Interim report

Status Update

Aug 18, 2025

Transcript

Press release

Company Presentation

Jun 3, 2025

Slides

Company Presentation

Mar 6, 2025

Slides

2024

Q4 2024

Apr 29, 2025

Annual report20-F

Q3 2024

Nov 28, 2024

Interim report

Q2 2024

Aug 29, 2024

Interim report

Q1 2024

Jun 13, 2024

Interim report

2023

Q4 2023

Apr 30, 2024

Annual report

Q3 2023

Nov 8, 2023

Interim report

Q2 2023

Aug 31, 2023

Interim report

Q1 2023

Jun 15, 2023

Interim report

2022

Q4 2022

Apr 10, 2023

Earnings release6-K

Annual report20-F

Q3 2022

Dec 1, 2022

Interim report

Q2 2022

Aug 21, 2022

Interim report

Q1 2022

May 26, 2022

Interim report

2021

Q4 2021

Apr 29, 2022

Earnings release6-K

Q3 2021

Nov 22, 2021

Earnings release6-K

Q2 2021

Aug 9, 2021

Earnings release6-K